Trial Details
Not recruitingBasic Information
| Clinical ID | c3291 |
|---|---|
| Identifier | NCT00936585 |
| Trial Title | NIH SUBSTUDY:Randomized, Double-blind, Placebo-controlled, Parallel-group Proof-of-concept Study to Assess the Efficacy, Safety and Tolerability of Two Single Infusions of AIN457 in Patients With Moderate to Severe Active Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | Yes |
|---|---|
| Conditions | Colitis;Crohn's Disease;Inflammatory Bowel Disease;Colitis;Crohn's Disease;Inflammatory Bowel Disease;Colitis;Crohn's Disease;Inflammatory Bowel Disease;Colitis;Crohn's Disease;Inflammatory Bowel Disease |
| Interventions | Other: Immunologic Monitoring;Other: Immunologic Monitoring;Other: Immunologic Monitoring;Other: Immunologic Monitoring |
Participant Information
| Sponsor | National Institutes of Health Clinical Center (CC) |
|---|---|
| City | - |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | Interventional |
|---|---|
| Phase | Not Available |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | 2016-01-11 |
| Completion Date | - |